{"id":2671,"date":"2017-07-21T09:44:54","date_gmt":"2017-07-21T13:44:54","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2671"},"modified":"2017-07-21T21:10:41","modified_gmt":"2017-07-22T01:10:41","slug":"ipo-pipeline-update-new-filings-terms-added-week-ending-7-21-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-new-filings-terms-added-week-ending-7-21-17\/","title":{"rendered":"IPO Pipeline Update: New Filings &#038; Terms Added (Week ending 7.21.17)"},"content":{"rendered":"<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-1.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-2672\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-1.png\" alt=\"chart (1)\" width=\"746\" height=\"461\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-1.png 746w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-1-600x371.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-1-300x185.png 300w\" sizes=\"(max-width: 746px) 100vw, 746px\" \/><\/a><\/p>\n<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of July 21, 2017. No SPACs or Unit Offerings are included.<\/p>\n<p><strong>NEW FILINGS<\/strong><\/p>\n<p>Company: <strong>BJ Services, Inc.<\/strong><br \/>\nSymbol: BJS<br \/>\nDescription: They are the largest North American-focused, pure-play pressure pumping services provider.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs &amp; Co., Morgan Stanley, Credit Suisse<br \/>\nFiled: 7-14-17<br \/>\nListed Cash Raise: $100 million<\/p>\n<p>Company: <strong>Genprex, Inc.<\/strong><br \/>\nSymbol: GNPX<br \/>\nDescription: Genprex is a clinical stage gene therapy company developing a new approach to treating cancer, based upon their novel proprietary technology platform, including their initial product candidate, Oncoprex immunogene therapy, or Oncoprex.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Network 1 Financial Securities<br \/>\nFiled: 7-21-17<br \/>\nListed Cash Raise: $22.5 million<\/p>\n<p>Company:       Nexpoint Multifamily Capital Trust<br \/>\nSymbol:           NREF<br \/>\nDescription:    NREF will originate and structure preferred equity, alternative structured financing investments, mezzanine debt, bridge financing and first mortgage loans in properties benefiting from significant tenant diversification and short-term lease structures, including multifamily, storage and select-service and extended-stay hospitality properties.<br \/>\nTrade Date:     TBD<br \/>\nUnderwriter(s):  TBD<br \/>\nFiled: 7-21-17<br \/>\nListed Cash Raise: $10 million<\/p>\n<p><strong>TERMS ADDED<\/strong><\/p>\n<p>Company: <strong>Redfin Corporation<\/strong><br \/>\nSymbol: RDFN<br \/>\nDescription: Redfin is a technology-powered residential real estate brokerage.<br \/>\nShares: 9.2 million<br \/>\nPrice Range: $12.00-$14.00<br \/>\nTrade Date: 7\/28<br \/>\nUnderwriter(s): Goldman Sachs &amp; Co., Allen &amp; Company<br \/>\nCo-Manager: BofA Merrill Lynch, RBC Capital Markets, Oppenheimer &amp; Co., Stifel<br \/>\nFiled: 7-17-17<\/p>\n<p>Company: <strong>Sienna Biopharmaceuticals, Inc<\/strong><br \/>\nSymbol: SNNA<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics<br \/>\nShares: 4.3 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nTrade Date: 7\/27<br \/>\nUnderwriter(s): J.P. Morgan, Cowen, BMO Capital Markets<br \/>\nFiled: 7-17-17<\/p>\n<p>Company: <strong>Clementia Pharmaceuticals<\/strong><br \/>\nSymbol: CMTA<br \/>\nDescription: They are a clinical stage biopharmaceutical company that is developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need.<br \/>\nShares: 7.15 million<br \/>\nPrice Range: $13.00-$15.00<br \/>\nTrade Date: 8\/2<br \/>\nUnderwriter(s): Morgan Stanley, Leerink Partners<br \/>\nCo-Manager(s): Wedbush PacGrow, BTIG<br \/>\nTerms Added: 7-21-17<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of July 21, 2017. No SPACs or Unit Offerings are included. NEW FILINGS Company: BJ Services, Inc. Symbol: BJS Description: They are the largest North American-focused, pure-play pressure pumping services provider. Trade Date: TBD Underwriter(s): Goldman Sachs[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[1300,1275,1299,1295,1276],"class_list":["post-2671","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-bjs","tag-cmta","tag-gnpx","tag-rdfn","tag-snna"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2671"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2671\/revisions"}],"predecessor-version":[{"id":2689,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2671\/revisions\/2689"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}